Latest Regulatory News

Toubani Resources has obtained the crucial environmental permit for its Kobada Gold Project, clearing the way for construction and initiating resettlement activities as planned.

Vital Metals has reported exceptional surface assay results from its Nechalacho Rare Earths and Niobium Project in Canada, revealing ultra-high-grade mineralisation beyond its flagship Tardiff deposit. These findings underpin an aggressive resource expansion strategy ahead of a 2027 Pre-Feasibility Study.

Celsius Resources has raised A$9.3 million through a well-supported institutional placement, strengthening its balance sheet to advance the financing and early development of its flagship MCB copper-gold project in the Philippines.

Bindi Metals has secured regulatory approval to commence its maiden drilling program at the Ravni Gold Project in Serbia, while historic drill core resampling is underway with assay results expected soon.

A recent expert panel convened by Novitas has strongly endorsed Pacific Edge’s urine-based Cxbladder tests for hematuria evaluation, recommending Medicare coverage based on robust clinical evidence and patient care benefits.

EMVision Medical Devices reported a $3.97 million loss for H1 2026, up 11% year-on-year, driven by increased share-based payments and expanded clinical activities. The company secured a $3 million government grant to advance stroke diagnosis in regional Australia.

Clarity Pharmaceuticals reports another metastatic prostate cancer patient achieving undetectable disease markers in its Phase II SECuRE trial, reinforcing promising efficacy and safety of its Cu-SAR-bisPSMA radiopharmaceutical.

Greatland Resources posted a robust half-year profit of $342.9 million, driven by full ownership of the Telfer mine and a strong operational ramp-up. The Havieron feasibility study confirms a world-class gold-copper project, setting the stage for future growth.

Electro Optic Systems reported a 27% revenue drop to $128.5 million in FY2025 but posted a net profit of $18.6 million, boosted by the sale of EM Solutions. The company strengthened its position with key contract wins and acquisitions, including the UK-based Interceptor business and a conditional deal for MARSS.

QMines Limited has significantly upgraded its Develin Creek Mineral Resource, increasing Indicated Resources by 46% and total resources by 14%, setting the stage for Phase 2 development planning.

Regis Healthcare reported a strong 18.4% revenue increase to $667.7 million for H1 2026, despite a 44.8% drop in statutory net profit. The company expanded its aged care portfolio through key acquisitions and declared a fully franked interim dividend.

Minerals 260 has locked in a $220 million strategic funding deal with Franco-Nevada, boosting development and de-risking the Bullabulling Gold Project in Western Australia. This marks Franco-Nevada’s largest Australian investment to date.